Q-omics provides the consensus-scored USP9YP20 profile across patient tissues and cancer cell-line models. USP9YP20 expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, USP9YP20 RNA expression shows 56 significant mutation-linked associations, with the highest sampling consensus in LUSC. Together, these results highlight STAD, and LUSC as cancer lineages where USP9YP20 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for USP9YP20 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes USP9YP20 survival associations across molecular data types. USP9YP20 RNA expression shows survival associations in the most cancer types (6). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

USP9YP20 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	6	STAD (144)	view →

This table ranks reproducible USP9YP20 RNA expression–survival associations across cancer types. High USP9YP20 expression shows unfavorable associations in STAD, LUAD, LAML, SKCM, KIRC and SARC. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify STAD as the clearest survival context for USP9YP20 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.086	0.690	<.001	144	view →
LUAD	OS	Tertile	All	0.113	0.812	<.001	72	view →
LAML	DFS	Tertile	All	0.081	0.572	.003	36	view →
SKCM	OS	Tertile	All	0.259	0.787	.010	36	view →
KIRC	OS	Tertile	All	0.260	0.805	.012	36	view →
SARC	DFS	Tertile	All	0.096	0.611	.005	18	view →

Pink = unfavorable, green = favorable. all 6 lineages →

USP9YP20-STAD (OS)

Kaplan–Meier survival curve for USP9YP20 RNA expression in STAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with USP9YP20 in patient tissues and cancer cell lines. In patient samples, USP9YP20 shows the broadest associations at the RNA and protein expression levels, with LUSC recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Mutation	56	LUSC (49)	view →
RNA	41	LUSC (36)	view →